Why partner with EFNR?
The European Federation of NeuroRehabilitation Societies (EFNR) unites a pan-European network of clinicians, researchers, and policy experts dedicated to improving outcomes after stroke, brain injury, and neurodegenerative diseases.
Through our community, we connect:
- Clinicians and rehabilitation centers across Europe and beyond
- Biostatisticians, data managers, and AI experts with experience in complex big data
- Top centers providing high-throughput ‘omics’ technologies (DNA, RNA, proteins, metabolites)
- Health economists and policy specialists with a proven record in shaping healthcare systems
Together, we can deliver robust evidence and transformative insights to industry, payers, regulators, and patients.
Key Opportunities
Real-World Evidence (RWE)
We support projects that generate actionable evidence beyond randomized clinical trials:
- Pan-European registries for stroke, traumatic brain injury, and neurodegenerative conditions
- Comparative effectiveness studies of rehabilitation strategies, pharmacological adjuncts, and digital therapeutics
- Observational studies (prospective or retrospective) addressing patient pathways, treatment gaps, and epidemiology
- Local market insights with focused budgets – ideal for payer engagement and policy dialogue.
Innovation & Technology Evaluation
EFNR offers a trusted environment to evaluate novel interventions:
- Digital rehabilitation and telemedicine platforms
- Biomarker studies
- Virtual and augmented reality, brain–computer interfaces (BCI), and robotics
- Wearable sensors and patient-generated health data
Projects can include multicenter pilots, usability assessments, and post-market performance studies.
Health Economics & Policy Impact
EFNR partners with industry and health authorities to:
- Conduct cost-of-illness, cost-utility, and budget-impact analyses
- Map rehabilitation service capacity, workforce, and access delays
- Produce policy briefs and consensus pathways to inform national and European decision-making.
Education & Dissemination
Through our postgraduate curriculum, young investigator academy, and ECNR congress, partners can:
- Support training modules on RWE methods, neurorehab innovations, and health economics
- Disseminate results through satellite symposia, late-breaker sessions, and consensus workshops
- Strengthen workforce capacity across Europe in line with EFNR’s mission.
Why Real-World Evidence Matters?
Randomized clinical trials remain essential, but they often exclude the very populations we care for in neurorehabilitation. RWE complements RCTs by providing:
- Faster, more cost-effective insights
- Access to diverse and representative patient populations
- Detection of rare outcomes
- Understanding of patient behavior and care pathways
- Evidence that informs both global decisions and local reimbursement
Our Commitment to Scientific Integrity
All EFNR-led projects follow best practices for transparent and high-quality RWE:
- Pre-specified research protocols
- Robust statistical and methodological oversight
- Independent data analysis by EFNR experts
- Commitment to publication in peer-reviewed journals
- Compliance with GDPR and international ethical standards
How to Partner
EFNR invites:
- Industry partners (pharma, medtech, digital health, diagnostics)
- Health systems and payers
- Academic consortia and patient organizations
Together, we can create sustainable evidence platforms that transform neurorehabilitation care across Europe.
